HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
Metrics: PDF 1770 views | HTML 3004 views | ?
Laura Pellegrini1, Jiaming Xue1,3, David Larson1, Sandra Pastorino1, Sandro Jube2, Kelly H. Forest3, Zeyana Salim Saad-Jube4, Andrea Napolitano1,5, Ian Pagano1, Vishal S. Negi5, Marco E. Bianchi6, Paul Morris7, Harvey I. Pass8, Giovanni Gaudino1, Michele Carbone1, Haining Yang1
1University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA
2University of Hawai'i at Manoa, Department of Cell and Molecular Biology, John A. Burns School of Medicine, Honolulu, HI, USA
3Leeward Community College, Mathematics and Sciences Division, University of Hawai'i System, Pearl City, HI, USA
4University of Hawai'i at Manoa, Myron B. Thompson School of Social Work, Office of Public Health and Center on Aging, Honolulu, HI, USA
5University of Hawai'i at Manoa, Department of Molecular Biosciences and Bioengineering, Honolulu, HI, USA
6San Raffaele University and Research Institute, Milan, Italy
7Department of Thoracic Surgery, Queen's Medical Center, Honolulu, HI, USA
8New York University School of Medicine, Department of Cardiothoracic Surgery, New York, NY, USA
Haining Yang, email: [email protected]
Michele Carbone, email: [email protected]
Keywords: HMGB1, RAGE, ethyl pyruvate, mesothelioma, therapeutic
Received: June 30, 2016 Accepted: January 23, 2017 Published: February 07, 2017
Human malignant mesothelioma (MM) is an aggressive cancer linked to asbestos and erionite exposure. We previously reported that High-Mobility Group Box-1 protein (HMGB1), a prototypic damage-associated molecular pattern, drives MM development and sustains MM progression. Moreover, we demonstrated that targeting HMGB1 inhibited MM cell growth and motility in vitro, reduced tumor growth in vivo, and prolonged survival of MM-bearing mice. Ethyl pyruvate (EP), the ethyl ester of pyruvic acid, has been shown to be an effective HMGB1 inhibitor in inflammation-related diseases and several cancers. Here, we studied the effect of EP on the malignant phenotype of MM cells in tissue culture and on tumor growth in vivo using an orthotopic MM xenograft model. We found that EP impairs HMGB1 secretion by MM cells leading to reduced RAGE expression and NF-κB activation. As a consequence, EP impaired cell motility, cell proliferation, and anchorage-independent growth of MM cells. Moreover, EP reduced HMGB1 serum levels in mice and inhibited the growth of MM xenografts.
Our results indicate that EP effectively hampers the malignant phenotype of MM, offering a novel potential therapeutic approach to patients afflicted with this dismal disease.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.